Jul 31, 2024, 11:44
Michiel van der Heijden: Explaining inconsistent results in urothelial cancer with chemo plus IO
Michiel van der Heijden, Medical Oncologist at Netherlands Cancer Institute, shared on X:
“Results of chemo plus IO have produced inconsistent results in urothelial cancer. Opposing effects of pro- and anti-inflammatory changes may explain some of this.”
Read further.
Source: Michiel van der Heijden/X
Authors: Maksim A. Chelushkin, Jeroen van Dorp, Sandra van Wilpe, Iris M. Seignette, Jan-Jaap J. Mellema, Maartje Alkemade, Alberto Gil-Jimenez, Dennis Peters, Wim Brugman, Chantal F. Stockem, Erik Hooijberg, Annegien Broeks, Bas W.G. van Rhijn, Laura S. Mertens, Antoine G. Van der Heijden, Niven Mehra, Maurits L. van Montfoort, Lodewyk F.A. Wessels, Daniel J. Vis, Michiel S. Van der Heijden
Alberto Gil-Jimenez
Annegien Broeks
Antoine G. Van der Heijden
Bas W.G. van Rhijn
cancer
Chantal F. Stockem
Daniel J. Vis
Dennis Peters
Erik Hooijberg
Iris M. Seignette
Jan-Jaap J. Mellema
Jeroen van Dorp
Laura S. Mertens
Lodewyk F.A. Wessels
Maartje Alkemade
Maksim A. Chelushkin
Maurits L. van Montfoort
Michiel S. Van der Heijden
Michiel van der Heijden
Netherlands Cancer Institute
Niven Mehra
OncoDaily
Oncology
Sandra van Wilpe
Wim Brugman
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19